Cargando…

Effect of enhanced recovery after surgery program on patient-reported outcomes and function recovery in patients undergoing liver resection for hepatocellular carcinoma

The aim of this study was to investigate the effect of enhanced recovery after surgery (ERAS) on perioperative outcomes, with an emphasis on patient-reported outcomes (PROs) and functional recovery. We compared the clinical outcomes in a cohort of 275 patients undergoing liver resection before and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Qiu Ping, Luo, Yan-Li, Xiao, Feng Ming, Wen, Tian-Fu, Wu, Meng-Hang, Juan-Wan, Xie, Ze-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254517/
https://www.ncbi.nlm.nih.gov/pubmed/32443312
http://dx.doi.org/10.1097/MD.0000000000020062
_version_ 1783539555805167616
author Ren, Qiu Ping
Luo, Yan-Li
Xiao, Feng Ming
Wen, Tian-Fu
Wu, Meng-Hang
Juan-Wan,
Xie, Ze-Rong
author_facet Ren, Qiu Ping
Luo, Yan-Li
Xiao, Feng Ming
Wen, Tian-Fu
Wu, Meng-Hang
Juan-Wan,
Xie, Ze-Rong
author_sort Ren, Qiu Ping
collection PubMed
description The aim of this study was to investigate the effect of enhanced recovery after surgery (ERAS) on perioperative outcomes, with an emphasis on patient-reported outcomes (PROs) and functional recovery. We compared the clinical outcomes in a cohort of 275 patients undergoing liver resection before and after the implementation of ERAS. The PROs were preoperatively and postoperatively compared until 14 days after surgery using the MD Anderson Symptom Inventory. The patients in the ERAS group experienced fewer symptoms and a shorter functional recovery time than the patients in the non-ERAS group. The group × time interactions were different between the groups for pain (F = 4.70, P = .001) and walking (F = 2.75, P = .03). On the 3rd, 4(th), and 5th days after surgery, the ERAS group experienced less pain and more walking than the non-ERAS group. The ERAS group experienced less fatigue (0.407 [95% confidence interval, CI: −0.795, −0.020], P = .035), less sleep interference (0.615 [95% CI: −1.215, −0.014], P = .045), a lower rate of reduced appetite (0.281 [95% CI: −0.442, −0.120], P = .001), and less abdominal distension (0.262 [95% CI: −0.504, −0.020], P = .034) than the non-ERAS group. Those in the ERAS group had a significantly shorter median time from surgery to mild fatigue (5.41 vs 6.87 days, P = .003), mild pain (4.45 vs 6.09 days, P = .001), mild interference when walking (3.85 vs 5.54 days, P < .001), and mild interference when sleeping (5.49 vs 7.43 days, P < .001). ERAS patients were more likely than non-ERAS patients to achieve a functional recovery (5.70 vs 6.79 days, P < .001) status in a shorter time period. The ERAS pathway, operation time, and the minimally invasive approach were independent predictors of functional recovery time. In hepatocellular carcinoma liver resection patients, the primary mechanism of ERAS is to reduce the postoperative interference burden and promote rapid functional recovery.
format Online
Article
Text
id pubmed-7254517
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-72545172020-06-15 Effect of enhanced recovery after surgery program on patient-reported outcomes and function recovery in patients undergoing liver resection for hepatocellular carcinoma Ren, Qiu Ping Luo, Yan-Li Xiao, Feng Ming Wen, Tian-Fu Wu, Meng-Hang Juan-Wan, Xie, Ze-Rong Medicine (Baltimore) 7100 The aim of this study was to investigate the effect of enhanced recovery after surgery (ERAS) on perioperative outcomes, with an emphasis on patient-reported outcomes (PROs) and functional recovery. We compared the clinical outcomes in a cohort of 275 patients undergoing liver resection before and after the implementation of ERAS. The PROs were preoperatively and postoperatively compared until 14 days after surgery using the MD Anderson Symptom Inventory. The patients in the ERAS group experienced fewer symptoms and a shorter functional recovery time than the patients in the non-ERAS group. The group × time interactions were different between the groups for pain (F = 4.70, P = .001) and walking (F = 2.75, P = .03). On the 3rd, 4(th), and 5th days after surgery, the ERAS group experienced less pain and more walking than the non-ERAS group. The ERAS group experienced less fatigue (0.407 [95% confidence interval, CI: −0.795, −0.020], P = .035), less sleep interference (0.615 [95% CI: −1.215, −0.014], P = .045), a lower rate of reduced appetite (0.281 [95% CI: −0.442, −0.120], P = .001), and less abdominal distension (0.262 [95% CI: −0.504, −0.020], P = .034) than the non-ERAS group. Those in the ERAS group had a significantly shorter median time from surgery to mild fatigue (5.41 vs 6.87 days, P = .003), mild pain (4.45 vs 6.09 days, P = .001), mild interference when walking (3.85 vs 5.54 days, P < .001), and mild interference when sleeping (5.49 vs 7.43 days, P < .001). ERAS patients were more likely than non-ERAS patients to achieve a functional recovery (5.70 vs 6.79 days, P < .001) status in a shorter time period. The ERAS pathway, operation time, and the minimally invasive approach were independent predictors of functional recovery time. In hepatocellular carcinoma liver resection patients, the primary mechanism of ERAS is to reduce the postoperative interference burden and promote rapid functional recovery. Wolters Kluwer Health 2020-05-15 /pmc/articles/PMC7254517/ /pubmed/32443312 http://dx.doi.org/10.1097/MD.0000000000020062 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 7100
Ren, Qiu Ping
Luo, Yan-Li
Xiao, Feng Ming
Wen, Tian-Fu
Wu, Meng-Hang
Juan-Wan,
Xie, Ze-Rong
Effect of enhanced recovery after surgery program on patient-reported outcomes and function recovery in patients undergoing liver resection for hepatocellular carcinoma
title Effect of enhanced recovery after surgery program on patient-reported outcomes and function recovery in patients undergoing liver resection for hepatocellular carcinoma
title_full Effect of enhanced recovery after surgery program on patient-reported outcomes and function recovery in patients undergoing liver resection for hepatocellular carcinoma
title_fullStr Effect of enhanced recovery after surgery program on patient-reported outcomes and function recovery in patients undergoing liver resection for hepatocellular carcinoma
title_full_unstemmed Effect of enhanced recovery after surgery program on patient-reported outcomes and function recovery in patients undergoing liver resection for hepatocellular carcinoma
title_short Effect of enhanced recovery after surgery program on patient-reported outcomes and function recovery in patients undergoing liver resection for hepatocellular carcinoma
title_sort effect of enhanced recovery after surgery program on patient-reported outcomes and function recovery in patients undergoing liver resection for hepatocellular carcinoma
topic 7100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254517/
https://www.ncbi.nlm.nih.gov/pubmed/32443312
http://dx.doi.org/10.1097/MD.0000000000020062
work_keys_str_mv AT renqiuping effectofenhancedrecoveryaftersurgeryprogramonpatientreportedoutcomesandfunctionrecoveryinpatientsundergoingliverresectionforhepatocellularcarcinoma
AT luoyanli effectofenhancedrecoveryaftersurgeryprogramonpatientreportedoutcomesandfunctionrecoveryinpatientsundergoingliverresectionforhepatocellularcarcinoma
AT xiaofengming effectofenhancedrecoveryaftersurgeryprogramonpatientreportedoutcomesandfunctionrecoveryinpatientsundergoingliverresectionforhepatocellularcarcinoma
AT wentianfu effectofenhancedrecoveryaftersurgeryprogramonpatientreportedoutcomesandfunctionrecoveryinpatientsundergoingliverresectionforhepatocellularcarcinoma
AT wumenghang effectofenhancedrecoveryaftersurgeryprogramonpatientreportedoutcomesandfunctionrecoveryinpatientsundergoingliverresectionforhepatocellularcarcinoma
AT juanwan effectofenhancedrecoveryaftersurgeryprogramonpatientreportedoutcomesandfunctionrecoveryinpatientsundergoingliverresectionforhepatocellularcarcinoma
AT xiezerong effectofenhancedrecoveryaftersurgeryprogramonpatientreportedoutcomesandfunctionrecoveryinpatientsundergoingliverresectionforhepatocellularcarcinoma